BOULDER, CO, Think Bioscience, a synthetic biology company, has raised $17M in an oversubscribed Seed round led by Innovation Endeavors and Xora Innovation.
Think Bioscience, a synthetic biology company focused on developing small-molecule therapeutics that target difficult-to-drug proteins, has raised $17M in an oversubscribed Seed round led by Innovation Endeavors and Xora Innovation, with participation from AV8 Ventures, Buff Gold Ventures, and LiquidMetal Ventures.
Returning pre-seed investors include Xora, Wireframe Ventures, and Axial VC. Think is a spin-out from CU Boulder and is a client company of Innosphere Ventures' incubation program.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
